Sunwin International Neutraceuticals, Inc. Launches a New Series of Veterinary Disinfectants against Bird Flu Virus FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–March 15, 2005–Sunwin International Neutraceuticals, Inc. (OTCBB:SUWN), a leading manufacturer of Chinese herbs, veterinary medicines and low calorie natural sweetener (Stevia) in China, announced today it has launched a new series of veterinary disinfectants for fighting Bird Flu Virus that threatens to create a human pandemic. Sunwin’s scientists have developed a new series of veterinary disinfectants against Bird Flu Virus based on Chinese herbal technology that Sunwin owns. This product can effectively kill any kind of Bird Flu Virus while it meets national sanitary standards. The most important feature of this new product is that it is a “green” product which does not cause pollution to the environment and with no toxic residual. This series of products is becoming more and more popular in the market place because they are easy to use and safe to the environment. The greatest concern is that these ever-changing avian viruses could develop the ability to spread from person to person, resulting in a fast-moving, global pandemic. Pandemic influenza has the potential to devastate human health throughout the world, and therefore an effective disinfectant is crucial to prevent us from global pandemic in the first place. Tongtong Lin, Sunwin’s CEO, commented, “Sunwin will apply more resources in marketing and promotional events to increase its market share. We expect the sales of our disinfectants will continue to grow substantially, as the Chinese government is committed to controlling measures nationwide and considers the fight against bird flu as a long-term commitment. Our new products are one of the most cost-effective tools for tens of millions of Chinese farmers in containing the spread of any avian influenza virus. In the meantime, Sunwin is negotiating with foreign firms and seeks to export this series of products to foreign countries influenced by Bird Flu Virus.” About Sunwin International Neutraceuticals, Inc. Sunwin International Neutraceuticals, Inc. (“Sunwin”) is engaged in the areas of essential traditional Chinese medicine, 100% organic herbal medicine, neutraceutical products, natural sweetener (Stevioside), and animal medicine prepared from 100% organic herbal ingredients. As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. Sunwin also makes such value-added products as specialty veterinary food ingredients and specialty feed ingredients. The Sunwin family works closely with consumers to provide a quality, value, and a hybrid mix of agricultural products and services that meet growing demand. In 2002, Sunwin was recognized as one of the first 2,000 state-level companies that China authorized as the most important innovative high-tech pioneer businesses by the Chinese central government. Sunwin was awarded as one of 2002′s state-level biological product manufacturers in China. In 2003, Sunwin ranked as one of the top 50 companies of China’s Animal Related Health Care Product Pharmaceutical Industry. In 2003, Sunwin received an award of Shandong’s Top-Ten Innovative, High-Tech Businesses by the Province Government of Shandong. For more information about Sunwin, please visit http://www.sunwin.biz Safe Harbor Statement Certain of the statements set forth in this press release constitute “forward-looking statements.” Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words “estimate,” “project,” “intend,” “forecast,” “anticipate,” “plan,” “planning,” “expect,” “believe,” “will likely,” “should,” “could,” “would,” “may” or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company’s actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company’s ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company’s limited financial resources, domestic or global economic conditions — especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets. More information about the potential factors that could affect the Company’s business and financial results is included in the Company’s filings, available via the United States Securities and Exchange Commission.